Zydus Cadila has received tentative approval from the USFDA for Amlodipine Besylate and Benazepril Hydrochloride Capsules in the strength of 2.5 mg/10 mg, 5 mg/ 10 mg, 5 mg/ 20 mg and 10 mg/20 mg.

The approval by the US Food and Drug Administration (USFDA) is for Varenicline tablets of strengths 0.5 mg and 1 mg, Zydus said in a regulatory filing. The product will be launched shortly.

The U.S. arm of India's Zydus Cadila has initiated its second recall in the U.S. in the last 7 months, this time because tablets of a drug for high blood pressure were found to have brown spots.

Zydus Lifesciences gets final USFDA approval to mfg, market generic version of Varenicline tablets The approval by the US Food and Drug Administration (USFDA) is for Varenicline tablets of ...